Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Enterovirus A vaccine - Takeda

Next Previous
X
Search
Drug Profile

Enterovirus A vaccine - Takeda

Alternative Names: Coxsackie virus vaccine - Takeda; EV71 vaccine; Hand, foot and mouth disease (HFMD) vaccine - Takeda; HFMDVax; INV 21; TAK-021

Latest Information Update: 28 Jul 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SingVax
  • Developer Takeda Pharmaceuticals USA
  • Class Enterovirus vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Enterovirus A infections

Most Recent Events

  • 28 Jul 2022 No recent reports of development identified for phase-I development in Enterovirus A infections(Prevention, In volunteers) in Singapore (Injection)
  • 24 Jun 2020 Enterovirus A vaccine is still in phase I trials for Enterovirus A infections in Singapore
  • 28 Nov 2017 Enterovirus A vaccine is still in phase I trials for Enterovirus A infections in Singapore

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top